Tando reports “outstanding” initial vanadium results

Published 05-JUN-2018 12:31 P.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Tando Resources (ASX:TNO) this morning revealed initial metallurgical results from samples taken from outcropping magnetite “pipes” at its SPD Vanadium Project.

Overall, these results are excellent, confirming that these pipes represent significant upside, in addition to the historic Resource of 500Mt at the project.

The SPD Vanadium Project is a large, high-grade vanadium deposit located in the established vanadium production hub within the Bushveld Complex of South Africa. Based off tonnage and grade in concentrate, the project has potential to become a globally significant vanadium Resource.

This project is located in a similar geological setting to the mining operations of Rhovan (Glencore), Vametco (Bushveld Minerals) and Mapochs (International Resources Ltd) in the Gauteng region of South Africa.

Metallurgical testwork indicates successful separation of vanidiferous titanomagnetite can be achieved with low intensity magnetic separation. Scoping testwork was completed on high-grade samples (more than 2% vanadium) from magnetite pipes on the project.

Material tested had only undergone coarse crushing, suggesting potential for low comminution requirements. This supports TNO’s belief that material from the magnetic pipes could represent a “direct shipping” type material that may, after a relatively simple concentration process, be able to be sold to an end-user as feedstock for a downstream processing plant, or processed cost-effectively using a different method.

If comminution and magnetic separation results are consistent with these results for samples from elsewhere in the SPD Vanadium Project, there is potential for reduced CAPEX and OPEX costs for processing compared to other vanadium projects under development. This will be further tested and confirmed during future testwork on core samples from the forthcoming drill programme.

There is still a lot of work to do here and success is not guaranteed — consider your own personal circumstances before investing, and seek professional financial advice.

The current testwork programme will now move to testing the amenability of the concentrate to leaching. Two processing methodologies will be used: salt roasting, followed by acid leaching, and direct leaching from the magnetic concentrate. Both the established salt roasting process and direct leaching methods are similar to those developed by TNG Limited (ASX:TNG) and King River Copper (ASX:KRC).

TNO plans to test both these methods in detail in future studies at the SPD Vanadium Project to determine the optimum processing path to achieve a battery-grade product at economically viable costs.

Magnetic concentrate from the SPD Vanadium ProjectGlobal vanadium projects categorised by resource grade and grade in concentrate


General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X